外源性肺表面活性物质治疗早产儿重症肺炎的疗效观察

目的:观察外源性肺表面活性物质治疗早产儿重症肺炎的疗效。方法:选取我院收治的17例重症肺炎的早产儿患儿,随机分为观察组9例和对照组8例。对照组给予常规治疗,观察组在常规治疗的基础上加用肺表面活性物质治疗。结果:(1)观察组患者的症状体征消失时间、体征消失时间以及住院时间均较对照组患者的要短,比较差异有统计学意义(P<0.05)。(2)观察组患者的治疗显效率和总有效率优于对照组患者,比较差异有统计学意义(P<0.05)。结论:在抗感染治疗的基础上应用外源性肺表面活性物质治疗早产儿重症肺炎可以有效控制控制,起到良好的辅助治疗作用。

The Clinical Efficacy of External Lung Surface Active Substances Treat Premature Severe Pneumonia

Objective:We observed the clinical efficacy of external lung surface active substances treat premature severe pneumonia.Methods:17 cases of premature with severe pneumonia were randomly divided into the trial group(9 cases) and the control group(8 cases).The control group used the routine treatment,the observation group used lung surface activity material treatment based on routine treatment.Results:(1)The symptoms disappear time,signs disappeared time and hospitalization time in the observation group were shorter than in the control group,the comparative differences have statistically significant(P<0.05).(2)The significant efficiency and the total effective rate in the observation group were super than in the control group,the comparative differences have statistically significant(P<0.05).Conclusion:External lung surface active material treatment can effectively control the premature severe pneumonia,and have good auxiliary therapy effect on the base of anti-infection treatment.